Teladoc Health, Inc. (TDOC) income statement
TDOCNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3038% below fair value
$8.06−0.43 (-5.06%)
Close on Nov 18, 2026Market cap $1.47BP/E –Yield –
Teladoc Health, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 68.6%
- Operating margin
- -6.6%
- Net margin
- -6.3%
- Return on equity, FY2025
- -13.9%
Financial strength
- Current ratio
- 0.87
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 60.0%
Valuation
- P/E ratio
- –
- Price to sales
- 0.60
- Price to book
- 1.13
- Dividend yield
- –
See a number that looks wrong?